全文获取类型
收费全文 | 495652篇 |
免费 | 36042篇 |
国内免费 | 9026篇 |
专业分类
耳鼻咽喉 | 6285篇 |
儿科学 | 10037篇 |
妇产科学 | 12698篇 |
基础医学 | 65127篇 |
口腔科学 | 14235篇 |
临床医学 | 44821篇 |
内科学 | 95813篇 |
皮肤病学 | 9982篇 |
神经病学 | 32939篇 |
特种医学 | 17860篇 |
外国民族医学 | 122篇 |
外科学 | 72726篇 |
综合类 | 28747篇 |
现状与发展 | 21篇 |
一般理论 | 81篇 |
预防医学 | 26028篇 |
眼科学 | 12697篇 |
药学 | 43599篇 |
114篇 | |
中国医学 | 8540篇 |
肿瘤学 | 38248篇 |
出版年
2022年 | 3158篇 |
2021年 | 7120篇 |
2020年 | 5575篇 |
2019年 | 6279篇 |
2018年 | 8293篇 |
2017年 | 6975篇 |
2016年 | 6698篇 |
2015年 | 9075篇 |
2014年 | 12189篇 |
2013年 | 14086篇 |
2012年 | 19829篇 |
2011年 | 20758篇 |
2010年 | 13485篇 |
2009年 | 11812篇 |
2008年 | 17023篇 |
2007年 | 17760篇 |
2006年 | 17306篇 |
2005年 | 15767篇 |
2004年 | 13434篇 |
2003年 | 12729篇 |
2002年 | 11653篇 |
2001年 | 30607篇 |
2000年 | 30905篇 |
1999年 | 25692篇 |
1998年 | 6188篇 |
1997年 | 5177篇 |
1996年 | 4552篇 |
1995年 | 4352篇 |
1994年 | 3939篇 |
1993年 | 3304篇 |
1992年 | 16709篇 |
1991年 | 15403篇 |
1990年 | 14657篇 |
1989年 | 14358篇 |
1988年 | 12949篇 |
1987年 | 12377篇 |
1986年 | 11357篇 |
1985年 | 10515篇 |
1984年 | 7048篇 |
1983年 | 5732篇 |
1982年 | 2794篇 |
1979年 | 5592篇 |
1978年 | 3434篇 |
1977年 | 3035篇 |
1975年 | 2666篇 |
1974年 | 3142篇 |
1973年 | 2919篇 |
1972年 | 2893篇 |
1971年 | 2809篇 |
1969年 | 2577篇 |
排序方式: 共有10000条查询结果,搜索用时 234 毫秒
51.
52.
目的:调查新疆地区15~44岁青年艾滋病患者常见中医症状和证候。方法:通过收集886例新疆青年HIV/AIDS患者病历,建立病历基本信息提取表,内容包括人口学信息、诊断、症状、中医证候等信息。结果:新疆地区青年最常出现的症状以乏力(52.7%)、腰膝酸痛(50.8%)、健忘(44.8%)、口干(43.6%)、烦躁(41.4%)、头痛(40.0%)、肢体麻木(34.6%)、心悸(34.2%);证候分布以虚证454例次占51.3%为多,其次为虚实夹杂证288例次占32.5%,气阴两虚(25.1%)、气虚湿阻(23.1%)、肝郁气滞(12.1%)、肝肾阴虚(12.1%)、气郁痰凝(6.7%)、肺卫不固(6.3%)为多。结论:新疆青年HIV/AIDS患者中医症状以乏力、腰膝酸痛、健忘为多,从证候分布上以虚证、虚实夹杂证为多,气阴两虚、气虚湿阻、肝郁气滞多见。 相似文献
53.
ChiaChi Lin TsaiSheng Yang ChiaJui Yen Rebecca Cheng Junjun Liu Chiun Hsu 《The oncologist》2020,25(12)
Lessons Learned
- The combination of ramucirumab (8 mg/kg intravenous, day 1 every 2 weeks) and FOLFOX4 as first‐line treatment in patients with advanced hepatocellular carcinoma (HCC) was not sufficiently tolerated.
- Preliminary efficacy data suggest that the combination may provide clinical benefit to patients with HCC.
- Dose modification and patient selection should be considered for the future development of ramucirumab plus FOLFOX chemotherapy for advanced HCC.
54.
55.
目的探讨食管肿瘤与头颈部肿瘤患者在调强放疗期间营养状况和生活质量的相关性。方法选取2018年11月至2019年5月肿瘤放疗患者进行研究,采用NRS 2002和PG-SGA对患者进行营养评估,运用EORTC QLQ-C30进行生活质量测评,并分析两者之间相关性。结果41例患者中食管肿瘤23例,头颈部肿瘤18例,放疗后体重丢失35例,占85.36%,其中丢失≥5%体重患者19例,占46.34%,体重丢失>10%患者2例,占4.88%,平均丢失体重3.6kg。41例患者中合并骨髓抑制31例、低蛋白血症15例,电解质紊乱24例。放疗后,41例患者在总健康水平及功能方面得分均低于放疗前(P<0.05),症状方面如疼痛、疲倦、食欲丧失等得分均高于放疗前(P<0.05)。总健康水平、躯体功能、疼痛和食欲丧失等方面与营养状况存在明显相关性(P<0.05);而社会功能、情绪功能、气促和便秘与营养状况无明显相关性(P>0.05)。结论肿瘤患者在放疗期间的营养状况和生活质量存在相关性,应重视肿瘤放疗患者的营养评估及干预,改善患者躯体功能、疼痛、食欲等方面的生活质量,从而提高放疗效果。 相似文献
56.
Yi Su Jean W. Woo Timothy C.Y. Kwok 《Journal of the American Medical Directors Association》2019,20(1):83-89
Objectives
To examine the potential added value of a simple 5-item questionnaire for sarcopenia screening (SARC-F) to the Fracture Risk Assessment Tool (FRAX) for hip fracture risk prediction, in order to identify at-risk older adults for screening with dual-energy x-ray absorptiometry (DXA).Design
A prospective cohort study.Setting and participants
Two thousand Chinese men and 2000 Chinese women aged 65 years or older were recruited from local communities and were prospectively followed up for about 10 years.Measures
Areal bone mineral density (BMD) of hip and lumbar spine were measured by DXA at baseline. Ten-year FRAX probability of hip fracture was calculated using the baseline risk factors. Information from the baseline questionnaire was extracted to calculate a modified SARC-F score. The independent predictive values of SARC-F and FRAX questionnaire were evaluated using multivariate survival analysis. The added predictive values of SARC-F to FRAX for pre-DXA screening were examined.Results
During the follow-up, 63 (3.2%) men and 69 (3.5%) women had at least 1 incident hip fracture. SARC-F had an independent value of FRAX for hip fracture risk prediction, with an adjusted hazard ratio [95% confidence interval (CI)] of 1.24 (1.02, 1.52) and 1.15 (0.99, 1.13) in men and women, respectively. Compared with using FRAX, using SARC-F in conjunction with FRAX made the sensitivity for prediction rise from 58.7% to 76.2% in men and from 69.6% to 78.3% in women, with a nondecreased area under receiver operating characteristic curve of 0.67. Prescreening using FRAX in conjunction with SARC-F could save more than half of the DXA assessment than with no prescreening.Conclusions/Implications
SARC-F is associated with a modest increase in hip fracture risk, especially in men. Conjoint evaluation for sarcopenia in addition to FRAX screening may help identify older adults at higher risk of hip fracture for more intensive screening and/or preventive interventions. 相似文献57.
58.
59.
Shiyu Jiang Yan Qin Hongxin Jiang Biao Liu Jianming Shi Fanlu Meng Peng Liu Jianliang Yang Sheng Yang Xiaohui He Shengyu Zhou Lin Gui Hao Liu Jing Lin Han Han-Zhang Yuankai Shi 《International journal of cancer. Journal international du cancer》2020,147(9):2611-2620
Diffuse large B-cell lymphoma (DLBCL) is a clinically aggressive and heterogenous disease. Although most patients can be cured by immunochemotherapy, 30% to 40% patient will ultimately develop relapsed or refractory disease. Here, we investigated the molecular landscapes of patients with diverse responses to R-CHOP. We performed capture-based targeted sequencing on baseline samples of 105 DLBCL patients using a panel consisting of 112 lymphoma-related genes. Subsequently, 81 treatment-naïve patients with measurable disease and followed for over 1 year were included for survival analysis. Collectively, the most commonly seen mutations included IGH fusion (69%), PIM1(33%), MYD88 (29%), BCL2 (29%), TP53 (29%), CD79B (25%) and KMT2D (24%). Patients with TP53 mutations were more likely to have primary refractory disease (87.0% vs 50.0%, P = .009). For those with TP53 disruptive mutations, 91.7% patients were in the primary refractory group. Interestingly, BCL-2 somatic hypermutation was only seen in patients without primary refractory disease (P = .014). In multivariate analysis, BCL-2 amplification (hazard ratio [HR] = 2.94, P = .022), B2M mutation (HR = 2.99, P = .017) and TP53 mutation (HR = 3.19, P < .001) were independently associated with shorter time to progression (TTP). Furthermore, TP53 mutations was correlated with worse overall survival (P = .049). Next, we investigated mutation landscape in patients with wild-type (WT) TP53 (n = 58) and found that patients harboring MYD88 L265P had significantly inferior TTP than those with WT or non-265P (P = .046). Our study reveals the mutation spectrum of treatment-naive Chinese DLBCL patients. It also confirms the clinical significance of TP53 mutations and indicates the prognostic value of MYD88 L265P in TP53 WT patients. 相似文献
60.
Schaff Lauren R. Yan Dongyao Thyparambil Sheeno Tian Yuan Cecchi Fabiola Rosenblum Marc Reiner Anne S. Panageas Katherine S. Hembrough Todd Lin Andrew L. 《Journal of neuro-oncology》2020,146(1):163-170
Journal of Neuro-Oncology - Understanding the molecular landscape of glioblastoma (GBM) is increasingly important in the age of targeted therapy. O-6-Methylguanine-DNA methyltransferase (MGMT)... 相似文献